Hypersensitivity associated with sugammadex administration: A systematic review

Anaesthesia

Volumn 69, Issue 11, 2014, Pages 1251-1257

  Tsur, A ^a   Kalansky, A ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

SUGAMMADEX; GAMMA CYCLODEXTRIN DERIVATIVE;

AWARENESS; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; HUMAN; INTRACUTANEOUS TEST; PRICK TEST; REVIEW; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; NEUROMUSCULAR BLOCKING;

DRUG HYPERSENSITIVITY; GAMMA-CYCLODEXTRINS; HUMANS; NEUROMUSCULAR BLOCKADE;

EID: 84908447605     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.12736     Document Type: Review

References (32)

1. Booij LH,. Cyclodextrins and the emergence of sugammadex. Anaesthesia 2009; 64 (Suppl. 1): 31-7.
2. Schaller SJ, Fink H,. Sugammadex as a reversal agent for neuromuscular block: an evidence-based review. Core Evidence 2013; 8: 57-67.
3. Naguib M,. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesthesia and Analgesia 2007; 104: 575-81.
4. Yang LP, Keam SJ,. Sugammadex: a review of its use in anaesthetic practice. Drugs 2009; 69: 919-42.
5. Sanfilippo M, Alessandri F, Shousha AA, Sabba A, Cutolo A,. Sugammadex and ideal body weight in bariatric surgery. Anesthesiology Research and Practice 2013; 2013: 389782.
6. Mirakhur RK,. Sugammadex in clinical practice. Anaesthesia 2009; 64 (Suppl 1): 45-54.
7. de Kam PJ, van Kuijk J, Prohn M, Thomsen T, Peeters P,. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation. Clinical Drug Investigation 2010; 30: 599-611.
8. Dahl V, Pendeville PE, Hollmann MW, Heier T, Abels EA, Blobner M,. Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery. European Journal of Anaesthesiology 2009; 26: 874-84.
9. Fuchs-Buder T, Meistelman C, Raft J,. Sugammadex: clinical development and practical use. Korean Journal of Anesthesiology 2013; 65: 495-500.
10. Woo T, Kim KS, Shim YH, et al. Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients. Korean Journal of Anesthesiology 2013; 65: 501-7.
11. Moher D, Liberati A, Tetzlaff J, Altman DG,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. British Medical Journal 2009; 339: b2535.
12. Heinzerling L, Mari A, Bergmann KC, et al. The skin prick test-European standards. Clinical and Translational Allergy 2013; 3: 3.
13. Simons FE, Ardusso LR, Bilo MB, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organization Journal 2011; 4: 13-37.
14. Motoyama Y, Izuta S, Maekawa N, Chuma R,. Case of anaphylactic reaction caused by sugammadex. Masui 2012; 61: 746-8.
15. Ohshita N, Tsutsumi YM, Kasai A, et al. Two cases of anaphylactoid reaction after administration of sugammadex. Masui 2012; 61: 1261-4.
16. Takahiro T, Haruyama N, Mae T, Doi K, Ozaki M,. Be careful about anaphylactic shock by antagonism of the neuromuscular blockade~ cases of anaphylactic shock induced by sugammadex. Critical Care Medicine 2012; 40 (Suppl. 1): 1145.
17. Takazawa T, Tomita Y, Nagata C, Saito S,. Three cases of suspected anaphylactic shock due to sugammadex. Journal of the Japanese Society of Intensive Care Medicine 2013; 20: 71.
18. Chon JY,. In the hour of Sugammadex. Korean Journal of Anesthesiology 2013; 64: 3-5.
19. Malinovsky JM, Plaud B, Debaene B, Mertes PM,. Do we know all indications and side effects of sugammadex? Annales Francaises D'anesthesie et de Reanimation 2011; 30: 709-10.
20. Savic L, Savic S, Hopkins PM,. Anaphylaxis to sugammadex. Anaesthesia and Intensive Care 2014; 42: 7-9.
21. Amao R, Zornow MH, Cowan RM, Cheng DC, Morte JB, Allard MW,. Use of sugammadex in patients with a history of pulmonary disease. Journal of Clinical Anesthesia 2012; 24: 289-97.
22. Godai K, Hasegawa-Moriyama M, Kuniyoshi T, et al. Three cases of suspected sugammadex-induced hypersensitivity reactions. British Journal of Anaesthesia 2012; 109: 216-8.
23. Sadleir PH, Russell T, Clarke RC, Maycock E, Platt PR,. Intraoperative anaphylaxis to sugammadex and a protocol for intradermal skin testing. Anaesthesia and Intensive Care 2014; 42: 93-6.
24. Menendez-Ozcoidi L, Ortiz-Gomez JR, Olaguibel-Ribero JM, Salvador-Bravo MJ,. Allergy to low dose sugammadex. Anaesthesia 2011; 66: 217-9.
25. Asahi Y, Omichi S, Adachi S, Kagamiuchi H, Kotani J,. Hypersensitivity reaction probably induced by sugammadex. Acta Anaesthesiologica Taiwanica 2012; 50: 183-4.
26. Soria A, Motamed C, Gaouar H, Chemam S, Amsler E, Frances C,. Severe reaction following sugammadex injection: hypersensitivity? Journal of Investigative Allergology and Clinical Immunology 2012; 22: 382.
27. Tokuwaka J, Takahashi S, Tanaka M,. Anaphylaxis after sugammadex administration. Canadian Journal of Anesthesia 2013; 60: 733-4.
28. Jeyadoss J, Kuruppu P, Nanjappa N, Van Wijk R,. Sugammadex hypersensitivity-a case of anaphylaxis. Anaesthesia and Intensive Care 2014; 42: 89-92.
29. Mimaru K, Gotoh K, Fujiwara K, Nakamura A, Nishimura A, Iijima T,. A case report of anaphylaxis associated with sugammadex administration in a pediatric oral surgical case. Journal of Japanese Dental Society of Anesthesiology 2013; 41: 199-200.
30. Chugo S,. Allied health: anaphylaxis after anesthetic reversal. World Allergy Organization Journal 2012; 5 (Suppl. 2): S78.
31. Peeters PA, van den Heuvel MW, van Heumen E, et al. Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96 mg/kg) in healthy adult subjects: a randomized, double-blind, crossover, placebo-controlled, single-centre study. Clinical Drug Investigation 2010; 30: 867-74.
32. Munro IC, Newberne PM, Young VR, Bar A,. Safety assessment of gamma-cyclodextrin. Regulatory Toxicology and Pharmacology 2004; 39 (Suppl. 1): S3-13.